Experience

Venatorx Pharmaceuticals, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Non Executive Director

  • Nov 2021 - Present

  Venatorx Pharmaceuticals is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug resistant bacterial infections and hard-to-treat viral infections. Venatorx Pharmaceuticals is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug resistant bacterial infections and hard-to-treat viral infections.



Knopp Neurosciences

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Sr. Director, Medicinal Chemistry

  • Apr 2018 - Oct 2021



Abbott

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Investigator, Group Leader, Sr. Group Leader, Medicinal Chemistry

  • Sep 2016 - Mar 2018

• Research Chemist, Sr. Research Chemist

  • Nov 2011 - Aug 2016

  * Discovered highly selective endothelin-A receptor antagonists, led to development compound ABT-546, entered Phase 1* Co-developed orally bioavailable nonpeptide renin inhibitors as antihypertensive agents, A-74273 advanced into preclinical toxicology studies and was outlicensing candidate* Investigated medicinal and process chemistry of antihypertensive angiotensin II receptor antagonists* Collaborated with protein NMR and combinatorial chemistry groups to develop anti-metastatic urinary-type plasminogen activator inhibitors Show less